Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion description "[Delineation of the adverse prognostic power of MDR1 in adult acute myeloid leukemia (AML) raised hopes that pharmacologic blockade of P-gp would improve the outcome of conventional cytotoxic therapy, perhaps more so than in any other human malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion evidence source_evidence_literature NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion SIO_000772 15217827 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion wasDerivedFrom befree-2016 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion wasGeneratedBy ECO_0000203 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- befree-2016 importedOn "2016-02-19" NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.